International Clinical Trial: A Study to Investigate Pharmacokinetics (PK), Safety, and Tolerability of VH4367310 in Healthy Adult Participants

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07818915) titled 'A Study to Investigate Pharmacokinetics (PK), Safety, and Tolerability of VH4367310 in Healthy Adult Participants' on Sept. 8.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Prevention. Masking: Triple (Participant, Care Provider, Investigator).

Primary Sponsor: ViiV Healthcare

Condition: HIV Infections

Intervention: Drug: VH4367310

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: September 15, 2026

Target Sample Size: 112

To know more, visit https://clinicaltrials.gov/study/NCT07818915

Published ...